AAPS 2019 Poster: Clinical formulation development for poorly soluble 14C labelled molecules

Check out our latest poster from AAPS 2019, 'Clinical Formulation Development for Poorly Soluble 14C Labelled Molecules.' 

Clinical studies involving the administration of 14C radio-labeled drug substances provide critical information during development. The main application is the regulatory ADME study to assess the mass balance, routes, and rates of elimination, and to provide plasma, urine, and faecal samples for metabolite profiling and structural identification.